Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats

Journal of the American College of Cardiology

Volumn 37, Issue 5, 2001, Pages 1461-1466

  Khaper, Neelam ^a   Singal, Pawan K ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CATALASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; LIPID HYDROPEROXIDE; LOSARTAN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DYSPNEA; HEART INFARCTION; HEMODYNAMICS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; CATALASE; GLUTATHIONE PEROXIDASE; HEART FAILURE, CONGESTIVE; LIPID PEROXIDATION; LOSARTAN; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; SUPEROXIDE DISMUTASE;

EID: 0035312884     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01126-3     Document Type: Article

References (36)

1. Development and prevention of congestive heart failure following myocardial infarction
2. Neuroendocrine changes in acute myocardial infarction
3. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival And Ventricular Enlargement trial (SAVE)
4. Effects of afterload reducing drugs on the pathogenesis of antioxidant changes and congestive heart failure in rats
5. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction
6. Mobilization of antioxidant vitamin pools and hemodynamic function following myocardial infarction
7. Usefulness of antioxidant vitamins in suspected acute myocardial infarction (The Indian Experiment of Infarct Survival-3)
8. Increased oxidative stress in patients with congestive heart failure
9. Antioxidant effects of angiotensin converting enzyme (ACE) inhibitors: Free radical and oxidant scavenging are sulphydryl-dependent, but lipid peroxidation is inhibited by both sulphydryl and non-sulphydryl-containing ACE inhibitors
10. Angiotensin II receptor blockade: An innovative approach to cardiovascular pharmacotherapy
11. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril
12. Direct selective blockade of the vascular angiotensin II receptors in therapy for hypertension and severe congestive heart failure
13. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
14. Regional differences in non-enzymatic antioxidants in the heart under control and oxidative stress conditions
15. A new assay for lipid peroxides using a methylene blue derivative
16. Protein measurements with the Folin phenol reagent
17. Losartan in heart failure: Hemodynamic effects and tolerability
18. Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart
19. Angiotensin-converting enzyme inhibition improves cardiac function: Role of bradykinin
20. Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin converting enzyme inhibitors in heart failure
21. Angiotensin II receptor subtypes and their selective non-peptide ligands
22. Comparative effects of chronic angiotensin converting enzyme inhibition angiotensin II type 1 receptor blockade on cardiac remodelling after myocardial infarction in the rat
23. Higher antioxidative capacity during a chronic stable heart hypertrophy
24. Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin
25. Doxorubicin-induced cardiomyopathy
26. Changes in antioxidant enzymes in isolated cardiac myocytes subjected to hypoxia-reoxygenation
27. Antioxidant changes in hypertrophied and failing guinea pig hearts
28. Identification of oxygen responsive elements in the 5′-flanking region of the human glutathione peroxidase gene
29. Oxygen-mediated myocardial damage during ischemia and reperfusion: Role of the cellular defenses against oxygen toxicity
30. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans
31. Angiotensin, LDL peroxidation and atherosclerosis
32. Evidence for a causal role of the renin-angiotensin system in nitrate tolerance
33. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone
34. Hypoxia-reoxygenation triggers coronary vasospasm in isolated bovine coronary arteries via tyrosine nitration of prostacyclin synthase
35. Antioxidant protection against epinephrine-induced arrhythmias
36. Experimental evidence to support ELITE